Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alexander Ureno"'
Autor:
Hsian-Rong Tseng, Alexander Montes, Amy Oppenheim, Margarit Sievert, Ann Go, Alexander Ureno, Neil A. Bhowmick, Yi-Tsung Lu, Suwicha Limvorasak, Karen A. Cavassani, Robert A. Figlin, Manisha Tripathi, Edwin M. Posadas, Andre Rogatko, Leland W.K. Chung, Jie-Fu Chen, Nancy P. Moldawer
Publikováno v:
Journal of Clinical Oncology. 35:5031-5031
5031 Background: The presence of VM in metastatic, castration-resistant prostate cancer (mCRPC) predicts poor survival. Cabozantinib (cabo) is a multi-kinase inhibitor that has clinical activity that did not improve survival in an unselected mCRPC po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76aea33e75a5d2d0958843acf27926b6
https://doi.org/10.1200/jco.2017.35.15_suppl.5031
https://doi.org/10.1200/jco.2017.35.15_suppl.5031
Autor:
Hao Ho, Hsian-Rong Tseng, Ker-Chau Li, Daniel Luthringer, Zunfu Ke, Jiaoti Huang, Alexander Ureno, Leland W.K. Chung, Edwin M. Posadas, Elisabeth Hodara, Jie-Fu Chen, Ann Go, Elizabeth Kaufman, Margarit Sievert
Publikováno v:
Cancer Research. 76:4962-4962
Introduction and Objective: Patients with metastatic castration-resistant prostate cancer (mCRPC) who develop visceral metastases (VM) have poorer clinical outcomes in comparison to those without VM. Currently, VM are discovered late in the clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8aeb7af65fdd9a0f4d61f81a37220bba
https://doi.org/10.1158/1538-7445.am2016-4962
https://doi.org/10.1158/1538-7445.am2016-4962
Autor:
Jie-Fu Chen, Hao Ho, Elisabeth Hodara, Shirley Cheng, Alexander Ureno, Ann Go, Margarit Sievert, Leland WK Chung, Hsian-Rong Tseng, Edwin M. Posadas
Publikováno v:
Journal of Clinical Oncology. 34:e16530-e16530
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd0edad4e07ee78dffe2126549673b79
https://doi.org/10.1200/jco.2016.34.15_suppl.e16530
https://doi.org/10.1200/jco.2016.34.15_suppl.e16530
Autor:
Zunfu Ke, Jie-Fu Chen, Hsian-Rong Tseng, Hao Ho, Margarit Sievert, Ann Go, Edwin M. Posadas, Elisabeth Hodara, Alexander Ureno, Leland W.K. Chung, Elizabeth Kaufman
Publikováno v:
Journal of Clinical Oncology. 34:64-64
64 Background: Patients with metastatic castration-resistant prostate cancer (mCRPC) who develop visceral metastasis (VM) have a poorer clinical outcome in comparison to those without VM. Their clinical course is aggressive and culminates in organ fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70890193fdc9979c9a7aed850ef4fdde
https://doi.org/10.1200/jco.2016.34.2_suppl.64
https://doi.org/10.1200/jco.2016.34.2_suppl.64